Beth Price is a dynamic strategist and co-founder of acCELLapy, where she plays a pivotal role in transforming the landscape of cancer treatment through innovative cell therapy solutions. With a robust background in healthcare management, Beth leverages her expertise to ensure that all cancer patients...
Beth Price is a dynamic strategist and co-founder of acCELLapy, where she plays a pivotal role in transforming the landscape of cancer treatment through innovative cell therapy solutions. With a robust background in healthcare management, Beth leverages her expertise to ensure that all cancer patients have access to cutting-edge therapies from reputable, quality programs conveniently located in their communities. Her commitment to enhancing patient care is evident in her leadership of key projects that focus on developing strategic partnerships with healthcare providers, research institutions, and technology innovators.
At acCELLapy, Beth is instrumental in refining competitive strategies that not only improve operational margins but also elevate the overall performance of healthcare organizations. Her comprehensive understanding of the healthcare continuum allows her to navigate complex systems, ensuring that integrated delivery networks and hospital systems can effectively implement cell therapy programs. By advising on business planning and risk management, she empowers organizations to make informed decisions that drive growth and sustainability.
Beth’s skills in forecasting and budgeting are critical as she oversees new business development initiatives aimed at expanding access to life-saving treatments. Her ability to foster collaboration among diverse stakeholders is a testament to her leadership style, which emphasizes transparency and shared goals. As acCELLapy continues to pioneer advancements in cell therapy, Beth Price remains at the forefront, championing a future where every cancer patient can receive the best possible care, right in their own community.
